FDA again bypasses advisers to remove black-box warnings from menopause treatments

Live updates

1. 1d ago

   FDA Removes Black-Box Warnings From Three More Menopause Treatments

   The Food and Drug Administration approved the removal of the strictest black-box warnings from three estradiol transdermal patches used to treat menopause symptoms. The October 30 update follows previous labeling changes on February 12, 2026, which removed safety warnings from six other menopausal hormone therapy products. The updated labels strip away previous warnings regarding cardiovascular disease, breast cancer, and probable dementia, though other clinical precautions remain in place. The latest regulatory shift occurred while women across the United States face an ongoing estrogen patch supply crunch and seek alternatives.

   Why it matters

   For years, prominent black-box warnings on menopause hormone therapy shaped treatment decisions before patients even reached a clinician's office. The recent label adjustments mark a continuation of policy shifts by health officials regarding hormone replacement therapies. Critics and ethics experts have raised concerns regarding transparency after the agency bypassed advisory committee input for the decisions.

   What is confirmed

   • The Food and Drug Administration approved the removal of black-box warnings from three estradiol transdermal patches.
   • The October 30 update follows February 12, 2026 labeling changes in which the agency removed safety-related boxed warnings from six other menopausal hormone therapy products.
   • Alicia Jackson endorsed a key FDA policy change on hormone replacement therapies while holding at least $115,000 in stock in a company providing access to menopause treatments.

   Still unconfirmed

   • Ethics experts called Alicia Jackson's endorsement an obvious conflict of interest.

   What to watch next

   • Further announcements from the FDA regarding advisory committee involvement in drug label changes
   • Developments in the ongoing US estrogen patch supply shortages and availability of alternatives
   Sources used for this update (21)

   1. www.theguardian.com — AI godfather Geoffrey Hinton: ‘We’re creating alien beings. I’m willing to be selfish and choose humans’ | Donald Trump
   2. www.propublica.org — Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In
   3. The Guardian — FDA again bypasses advisers to remove black-box warnings from menopause treatments
   4. Reuters — US estrogen supply crunch widens as women seek alternatives to scarce patches
   5. HHS.gov — Trump Administration Delivers for Women with Major Advances in Menopause Care
   6. KSL News — Can't find your estrogen patch? Here's why and what you can do
   7. Miami Herald — US health department to remove broad black box warning from three estrogen patch products
   8. WBTV — Estrogen patch prescriptions hard to fill for Charlotte-area women
   9. Contemporary OB/GYN — FDA removes boxed warnings from 3 more menopausal hormone therapy products
   10. Lynnwood Times — HHS Updates Labeling for Estradiol Patches to Advance Menopause Care
   11. www.contemporaryobgyn.net — FDA removes boxed warnings from 3 more menopausal hormone ...
   12. www.the-independent.com — Menopause patch black box warnings removed as American women ...
   confidence 95%